Consequently, searching for PTP1B inhibitors, especially inhibitory agents from natural and medicinal plants, microorganisms, and animals, are the main prospects in both type 2 diabetes treatment and obesity [7,8]. Here, PTPN1 is linked to obesity due to melanocortin 4 receptor deficiency.